Diamines & Chemicals Board of Directors

Get the latest insights into the leadership at Diamines & Chemicals. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Amit Mehta Executive Chairman
Mr. Rajendra Chhabra Prof.Director
Mr. Tanmay Godiawala Director
Mr. Dhruv Mehta Independent Director
Mrs. Kejal Pandya Independent Director
Mr. Priyam Jhaveri Independent Director

Diamines & Chemicals Share price

DIAMINESQ

393.6

14.50 (3.82%)
NSE
BSE
Last updated on 4 Sep, 2025 | 12:47 IST
BUYSELL
Today's High

418.80

Today's Low

375.40

52 Week Low

305.15

52 Week High

585.00

The current prices are delayed, login to your account for live prices

Diamines & Chemicals FAQs

The board at Diamines & Chemicals consists of experienced professionals, including Mr. Amit Mehta , Mr. Rajendra Chhabra , and others, overseeing the company’s strategic and corporate governance.

Directors at Diamines & Chemicals are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Amit Mehta is the current chairman at Diamines & Chemicals.

Executive directors at Diamines & Chemicals are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Diamines & Chemicals adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Diamines & Chemicals, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.